Contraindicated Enoxaparin, Eptifibatide Linked with Increased Risk for Bleeding, Mortality in Dialysis Patients Undergoing PCI

Cardiology Today -- The receipt of contraindicated antithrombotic medications after percutaneous coronary intervention was associated with an increased risk for bleeding and death in patients undergoing dialysis, study results suggested.